Drug interactions
Octreotide + Ponesimod
Severity: Major
Octreotide and Ponesimod: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ponesimod lowers heart rate when treatment is started, and octreotide can cause bradycardia and conduction disturbances. Taken together they may produce additive slowing of the heart rate and a higher risk of symptomatic bradycardia or AV block.
What this interaction means in plain words
Octreotide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Octreotide belongs to Endocrine; Ponesimod belongs to Central Nervous System.
Why it happens
Additive pharmacodynamic effects on heart rate and atrioventricular conduction.
What to do
Avoid starting ponesimod in patients taking octreotide unless the benefit outweighs the risk, and seek cardiology advice beforehand. If used together, perform a baseline ECG and monitor heart rate and rhythm during ponesimod initiation.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Ponesimod, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Octreotide
Other interactions of Ponesimod
- Fingolimod + Ponesimod Contraindicated
- Ponesimod + Siponimod Contraindicated
- Amiodarone + Ponesimod Major
- Amisulpride + Ponesimod Major
- Anagrelide + Ponesimod Major
- Anti-thymocyte + Ponesimod Major
Frequently asked questions
Can I take Octreotide with Ponesimod?
MediHelp rates the interaction as major. Octreotide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ponesimod lowers heart rate when treatment is started, and octreotide can cause bradycardia and conduction disturbances. Taken together they may produce additive slowing of the heart rate and a higher risk of symptomatic bradycardia or AV block.
How serious is the interaction between Octreotide and Ponesimod?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting ponesimod in patients taking octreotide unless the benefit outweighs the risk, and seek cardiology advice beforehand. If used together, perform a baseline ECG and monitor heart rate and rhythm during ponesimod initiation.
What other medicines interact with Octreotide?
MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
